All sponsors

ViiV Healthcare $GSK

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS15
PHASE 3 / 2-39
RECRUITING5
READOUTS ≤12 MONTHS1
READOUT SLIPPED >6 MO30%

Delay Index: of 10 active trials registered more than a year ago, 3 have moved their primary completion (readout) date by more than 6 months since first registration (median +3.2 months). See all sponsors →

Open ViiV Healthcare on the live radar map → 📅 $GSK readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
BMS-663068
NCT02362503
P3Active, not recruitingHIV Infections3712016-08-18 (-5 mo)
Cabotegravir (CAB) tablet
NCT02951052
P3Active, not recruitingInfection, Human Immunodeficiency Virus; HIV Infections6182018-05-29 (-2 mo)
Cabotegravir (CAB) tablet
NCT02938520
P3Active, not recruitingHIV Infections6312018-08-30 (+2 mo)
ATLAS-2M
NCT03299049
P3Active, not recruitingHIV Infections10492019-06-06
VOGUE
NCT05979311
P3Active, not recruitingHIV; HIV Infections4632026-04-15 (+8 mo)
EMBRACE
NCT05996471
P2Active, not recruitingHIV Infections1852026-05-27 (+19 mo)
Dolutegravir/Rilpivirine FDC
NCT05674656
P1/2RecruitingHIV Infections202026-06-01
CROWN
NCT06694805
P3Active, not recruitingHIV Infections3262026-08-19 (+3 mo)
CAB LA
NCT06741397
P2Active, not recruitingHIV Infections2292026-09-09
VH4524184
NCT07202546
P2RecruitingHIV Infections1862027-10-28 (+5 mo)
PALISADE
NCT06134362
P3Active, not recruitingHIV Infections29982029-03-14 (+23 mo)
CAB ULA
NCT07650916
P3RecruitingHIV5642029-08-13
CABNATE
NCT07275606
P1/2RecruitingHIV Infections442029-10-10
CINERGY
NCT07816250
P2Not yet recruitingHIV Infections2002032-06-10
PATH
NCT07393659
P3RecruitingHIV Infections1972032-09-14